Huons Group’s subsidiary Humedics has introduced its hyaluronic acid (HA) filler line, Elavie Premier, to the Thai market, signaling a strategic expansion into Southeast Asia.
The company held a launch symposium in Bangkok on Wednesday to unveil the three Elavie Premier products, as announced on Thursday.
Humedics secured approval from Thailand’s Food and Drug Administration (TFDA) last February for three products: Elavie Premier Deep Line, Elavie Premier Light, and Elavie Premier Soft.
The symposium, organized in partnership with local distributor M&V Thai, showcased the superior qualities of Elavie Premier.
Leading Thai medical experts presented the Elavie Premier fillers and demonstrated application techniques to an audience of about 100 local healthcare professionals.
Elavie Premier, an HA-based injectable filler, is engineered to provide natural volume and contour enhancement in targeted areas. Its balanced viscosity and elasticity allow for precise shaping and long-lasting results. The product also prioritizes user-friendly features for medical practitioners, improving injection comfort and maneuverability.
Kang Min Jong, CEO of Humedics, emphasized the significance of the launch, saying that the company’s entry into the Thai market marked a crucial milestone in Elavie’s global expansion strategy. He expressed confidence that the product’s ability to meet the needs of both local medical professionals and consumers would ensure its success in Thailand, adding that the launch would serve as a springboard for the company’s ambitious plans to expand into additional markets.